share_log

Shandong Jincheng Pharmaceutical Group (300233.SZ): In 2024, the company's overall revenue from exports to the United States will account for about 2%.

Gelonghui Finance ·  May 20 14:50

Gelonghui, on May 20, announced that Shandong Jincheng Pharmaceutical Group (300233.SZ) stated on the interactive platform that in 2024, the overall revenue from exports to the U.S. will account for about 2% of the company. The company will continue to pay attention to changes in tariff policies and maintain communication with customers!

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment